Parenteral Nutrition
Conditions
Keywords
Intestinal failure, Quality of life, Carer burden
Brief summary
Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients. The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN. This study will recruit HPN patients across the United Kingdom (UK) and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers.
Detailed description
Providing a person with food through a vein is known as parenteral nutrition (PN) or artificial tube feeding. This process is used when nutrients from food can't be taken in by the intestine (intestinal failure). Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients. It is important to assess patients quality of life and their own reported effects of the HPN. The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN. A recent study involving the use of the PNIQ in multiple hospitals in the UK, showed that those on fewer nights of HPN had better quality of life than those on more nights of HPN. Whilst this was useful for looking at quality of life at one time point, it is now important to assess change in quality life over time and any impact on family members quality of life. This study will recruit HPN patients across the UK and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers. The study is being funded by Shire Pharmaceuticals Ltd.
Interventions
PROCEDUREParenteral nutrition
Impact of parenteral nutrition on patient quality of life over time and impact on carer burden
Sponsors
Shire International GmbH
University of Manchester
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients: * All people in receipt of HPN including new patients * Those 18 years and over. Carers: * A family member or person involved in the healthcare of the participating patient. (We will ask patients to nominate their closest family member who in their opinion is potentially most effected by the parenteral feeding.) * Those 18 years and over.
Exclusion criteria
Patients: * Cannot give informed consent * Cannot read or write in English. Carers: • Family members not directly involved with caring for participants
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient reported outcomes | Baseline, five, 10 and 15 months post entry | Change in Patient reported outcomes (PNIQ score) in people receiving HPN. Score from 0-20, with 0 being high Quality of life and 20 being low quality of life. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Carer burden | Baseline | Caregiver burden (carer burden survey) in family members/close friends providing HPN healthcare to a patient receiving HPN. Score from 0-84, with 0 being no symptoms and 84 being very severe symptoms |
| Length of time receiving HPN | Baseline, five, 10 and 15 months post entry | Amount of time the patient has been receiving HPN (months/years) |
| Change in number of weekly HPN infusions | Baseline, five, 10 and 15 months post entry | How often the patient is connected to an infusion each week (numerical) |
| Change in number of hours connected to HPN infusions each night | Baseline, five, 10 and 15 months post entry | How many hours the patient is connected to an infusion each night (hours) |
Countries
United Kingdom
Outcome results
None listed